Data / Form D filings / Arno Therapeutics, Inc
Arno Therapeutics, Inc: Form D filings
Arno Therapeutics, Inc, a pharmaceuticals company in Flemington, NJ, filed 5 Form D notices with the SEC between 2010 and 2016. The latest, on August 30, 2016, reports $4.5 million sold of a $4.5 million offering to 15 investors.
Find out what Arno Therapeutics, Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 Route 31 North, Suite 104, Flemington, NJ, 08822
- Phone
- (862) 703-7170
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1195116
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 30, 2016 | New notice | $4,510,182 | $4,510,182 | $0 | 15 | Aug 15, 2016 | sec.gov |
| Nov 13, 2013 | New notice | $30,840,078 | $30,840,078 | $0 | 69 | Oct 29, 2013 | sec.gov |
| Dec 6, 2012 | Amendment | $18,425,000 | $11,130,000 | $7,295,000 | 16 | Nov 26, 2012 | sec.gov |
| Dec 5, 2012 | New notice | $18,425,000 | $11,130,000 | $7,295,000 | 16 | Nov 26, 2012 | sec.gov |
| Sep 23, 2010 | New notice | $13,225,000 | $8,387,000 | $4,838,000 | 24 | Sep 9, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jay F. Moorin | Director | |
| Tomer F. Kariv | Director | |
| Steven B. Ruchefsky | Director | |
| David M. Tanen | Director | |
| Yacov F. Reizman | Director | |
| William F. Hamilton, Ph.D. | Director | |
| Stefan M. Proniuk, Ph.D. | Executive Officer | |
| Arie S. Belldegrun, M.D. | Director | |
| Alexander Zukiwski, M.D. | Executive Officer, Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Aug 29, 2016 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Arno Therapeutics, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.